[HTML][HTML] Amorphous solid dispersions and the contribution of nanoparticles to in vitro dissolution and in vivo testing: Niclosamide as a case study
We developed an amorphous solid dispersion (ASD) of the poorly water-soluble molecule
niclosamide that achieved a more than two-fold increase in bioavailability. Notably, this …
niclosamide that achieved a more than two-fold increase in bioavailability. Notably, this …
[PDF][PDF] Amorphous solid dispersions and the confounding effect of nanoparticles in in vitro dissolution and in vivo testing: Niclosamide as a case study.
MO Jara, ZN Warnken, RO Williams III - scholar.archive.org
We developed an amorphous solid dispersion (ASD) of the poorly water-soluble molecule
niclosamide that achieved more than a 2-fold increase in bioavailability. Notably, this …
niclosamide that achieved more than a 2-fold increase in bioavailability. Notably, this …
Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study.
MO Jara, ZN Warnken, RO Williams 3rd - Pharmaceutics, 2021 - europepmc.org
We developed an amorphous solid dispersion (ASD) of the poorly water-soluble molecule
niclosamide that achieved a more than two-fold increase in bioavailability. Notably, this …
niclosamide that achieved a more than two-fold increase in bioavailability. Notably, this …
Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study. Pharmaceutics 2021, 13 …
MO Jara, ZN Warnken, RO Williams III - 2021 - search.proquest.com
We developed an amorphous solid dispersion (ASD) of the poorly water-soluble molecule
niclosamide that achieved a more than two-fold increase in bioavailability. Notably, this …
niclosamide that achieved a more than two-fold increase in bioavailability. Notably, this …
Amorphous solid dispersions and the confounding effect of nanoparticles in in vitro dissolution and in vivo testing: Niclosamide as a case study
MO Jara, ZN Warnken, RO Williams III - bioRxiv, 2020 - biorxiv.org
We developed an amorphous solid dispersion (ASD) of the poorly water-soluble molecule
niclosamide that achieved more than a 2-fold increase in bioavailability. Notably, this …
niclosamide that achieved more than a 2-fold increase in bioavailability. Notably, this …
[HTML][HTML] Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study
MO Jara, ZN Warnken, RO Williams III - Pharmaceutics, 2021 - ncbi.nlm.nih.gov
We developed an amorphous solid dispersion (ASD) of the poorly water-soluble molecule
niclosamide that achieved a more than two-fold increase in bioavailability. Notably, this …
niclosamide that achieved a more than two-fold increase in bioavailability. Notably, this …
[PDF][PDF] Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study. Pharmaceutics …
MO Jara, ZN Warnken, RO Williams III - 2021 - pdfs.semanticscholar.org
We developed an amorphous solid dispersion (ASD) of the poorly water-soluble molecule
niclosamide that achieved a more than two-fold increase in bioavailability. Notably, this …
niclosamide that achieved a more than two-fold increase in bioavailability. Notably, this …
[HTML][HTML] Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study
MO Jara, ZN Warnken, RO Williams - Pharmaceutics, 2021 - mdpi.com
We developed an amorphous solid dispersion (ASD) of the poorly water-soluble molecule
niclosamide that achieved a more than two-fold increase in bioavailability. Notably, this …
niclosamide that achieved a more than two-fold increase in bioavailability. Notably, this …
Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study
MO Jara, ZN Warnken, RO Williams 3rd - Pharmaceutics, 2021 - pubmed.ncbi.nlm.nih.gov
We developed an amorphous solid dispersion (ASD) of the poorly water-soluble molecule
niclosamide that achieved a more than two-fold increase in bioavailability. Notably, this …
niclosamide that achieved a more than two-fold increase in bioavailability. Notably, this …
Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study.
MO Jara, ZN Warnken, RO Williams III - Pharmaceutics, 2021 - search.ebscohost.com
We developed an amorphous solid dispersion (ASD) of the poorly water-soluble molecule
niclosamide that achieved a more than two-fold increase in bioavailability. Notably, this …
niclosamide that achieved a more than two-fold increase in bioavailability. Notably, this …